Languages
在制药领域,可靠且符合GMP要求的定量分析程序是确保质量控制的关键。本白皮书讨论了使用Fourier 80台式波谱仪对含氟活性药物成分(API)进行定量核磁共振(NMR)分析的优势。Fourier 80具备多核检测能力,可以轻松实现19F NMR定量分析,满足监管要求。利用19F NMR技术提供的高特异性,即便在复杂的混合物中,如成品药,也能大幅简化其定量分析程序的设计和实施工作。
I would like to attend
Anmeldung für die Teilnahme:
I would like to attend:
To learn how Bruker handles my personal data, please read Bruker´s Privacy Notice and Terms of Use.
* Please fill out the mandatory fields.
I agree to share my contact details with Bruker Corporation and its affiliates within the Bruker Group for the purpose of proceeding with my registration.